Lupšić, E.; Stojković, P.; Grozdanić, M.; Terzić-Jovanović, N.; Pajović, M.; Koutsougianni, F.; Alexopoulou, D.; Opsenica, I.M.; Pešić, M.; Podolski-Renić, A.
Novel Adamantane–Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells. Molecules 2025, 30, 4756.
https://doi.org/10.3390/molecules30244756
AMA Style
Lupšić E, Stojković P, Grozdanić M, Terzić-Jovanović N, Pajović M, Koutsougianni F, Alexopoulou D, Opsenica IM, Pešić M, Podolski-Renić A.
Novel Adamantane–Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells. Molecules. 2025; 30(24):4756.
https://doi.org/10.3390/molecules30244756
Chicago/Turabian Style
Lupšić, Ema, Pavle Stojković, Marija Grozdanić, Nataša Terzić-Jovanović, Milica Pajović, Fani Koutsougianni, Dimitra Alexopoulou, Igor M. Opsenica, Milica Pešić, and Ana Podolski-Renić.
2025. "Novel Adamantane–Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells" Molecules 30, no. 24: 4756.
https://doi.org/10.3390/molecules30244756
APA Style
Lupšić, E., Stojković, P., Grozdanić, M., Terzić-Jovanović, N., Pajović, M., Koutsougianni, F., Alexopoulou, D., Opsenica, I. M., Pešić, M., & Podolski-Renić, A.
(2025). Novel Adamantane–Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells. Molecules, 30(24), 4756.
https://doi.org/10.3390/molecules30244756
